Ethic Inc’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.11M | Buy |
7,420
+3,836
| +107% | +$575K | 0.02% | 589 |
|
2025
Q1 | $523K | Buy |
+3,584
| New | +$523K | 0.01% | 773 |
|
2024
Q4 | – | Sell |
-953
| Closed | -$258K | – | 1171 |
|
2024
Q3 | $258K | Sell |
953
-105
| -10% | -$28.5K | 0.01% | 927 |
|
2024
Q2 | $219K | Buy |
1,058
+105
| +11% | +$21.7K | 0.01% | 1009 |
|
2024
Q1 | $258K | Buy |
+953
| New | +$258K | 0.01% | 924 |
|
2022
Q3 | – | Sell |
-2,730
| Closed | -$584K | – | 807 |
|
2022
Q2 | $584K | Sell |
2,730
-974
| -26% | -$208K | 0.04% | 435 |
|
2022
Q1 | $1.05M | Buy |
3,704
+2,006
| +118% | +$570K | 0.07% | 303 |
|
2021
Q4 | $640K | Sell |
1,698
-82
| -5% | -$30.9K | 0.05% | 356 |
|
2021
Q3 | $735K | Sell |
1,780
-189
| -10% | -$78K | 0.08% | 279 |
|
2021
Q2 | $728K | Buy |
1,969
+821
| +72% | +$304K | 0.09% | 270 |
|
2021
Q1 | $333K | Buy |
+1,148
| New | +$333K | 0.06% | 356 |
|